Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesReceivables - OtherShares OutstandingShares Outstanding
Ratios

Odyssey Health (ODYY) Shares Issued (2020 - 2024)

Odyssey Health's quarterly Shares Issued came in at $9800.0 in Q1 2024, down 95.11% year-on-year from $200320.0 in Q1 2023, and down 78.61% quarter-over-quarter from $45820.0 in Q4 2023.

Odyssey Health has reported Shares Issued for 5 years, with the latest figure at $9800.0 in Q1 2024.

  • For the quarter ending Q1 2024, Shares Issued fell 95.11% year-over-year to $9800.0; the trailing twelve-month figure through Oct 2024 stood at $9800.0 (down 97.46% YoY), and the FY2024 full-year result was $55620.0, down 90.41% from the prior year.
  • Shares Issued for Q1 2024 stood at $9800.0, down from $45820.0 in the prior quarter.
  • The five-year high for Shares Issued was $2.4 million in Q2 2021, with the low at -$1.4 million in Q3 2022.
  • Average Shares Issued over 5 years is $283483.2, with a median of $131690.0 recorded in 2023.
  • Year-over-year, Shares Issued jumped 246.81% in 2021 and tumbled 542.11% in 2022.
  • Tracing ODYY's Shares Issued over 5 years: stood at $250000.0 in 2020, then jumped by 246.81% to $867035.0 in 2021, then slumped by 72.24% to $240710.0 in 2022, then sank by 80.96% to $45820.0 in 2023, then tumbled by 78.61% to $9800.0 in 2024.
  • The last three Shares Issued figures came in at $9800.0 (Q1 2024), $45820.0 (Q4 2023), and $7500.0 (Q3 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 116.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 164.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 81.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 68.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 12.70 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Odyssey Health - - - -

Historic Data

Download Data 🔒
DateValue
Jan 31, 2024 9,800.00
Jan 31, 2024 9,800.00
Oct 31, 2023 45,820.00
Oct 31, 2023 45,820.00
Jul 31, 2023 7,500.00
Jul 31, 2023 7,500.00
Apr 30, 2023 131,690.00
Apr 30, 2023 131,690.00
Jan 31, 2023 200,320.00
Jan 31, 2023 200,320.00
Oct 31, 2022 240,710.00
Oct 31, 2022 240,710.00
Jul 31, 2022 -1.39 Mn
Jul 31, 2022 -1.39 Mn
Apr 30, 2022 1.10 Mn
Apr 30, 2022 1.10 Mn
Oct 31, 2021 867,035.00
Oct 31, 2021 867,035.00
Jul 31, 2021 -216,753.00
Jul 31, 2021 -216,753.00
Apr 30, 2021 2.40 Mn
Apr 30, 2021 2.40 Mn
Jan 31, 2021 35,080.00
Jan 31, 2021 35,080.00
Oct 31, 2020 250,000.00
Oct 31, 2020 250,000.00